<DOC>
	<DOC>NCT00949767</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety profile, tolerability, pharmacokinetics and pharmacodynamics of ascending single doses of BMS-866949 in healthy subjects.</brief_summary>
	<brief_title>Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male 1855 Women not of child bearing potential, 1855 History of or current treatment for psychiatric illnesses, substance abuse or dependence History of a clinically significant neurological disorder (e.g., history of stroke, head trauma, etc.)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>